You are here

Heart Failure


Individuals with higher levels of cardiac troponin in their blood are at greater risk for developing heart failure for the first time, according to a meta-analysis published in JACC: Heart Failure.

The prevalence of left ventricular systolic dysfunction (LVSD) has declined over the last 30 years, and heart failure patients are increasingly demonstrating preserved ejection fraction versus reduced ejection fraction, according to a study published in JACC: Cardiovascular Imaging.

Previously sedentary, middle-aged adults who devote themselves to regular aerobic exercise for two years can increase their maximal oxygen uptake and decrease cardiac stiffness, according to new research published in Circulation.

Women who undergo hysterectomies—especially those under 35 years old—are nearly five times more likely to develop congestive heart failure and are at increased risk for a slew of other coronary complications, according to a study of more than 2,000 Minnesota women.

More than 10 percent of heart transplant recipients developed cancer between one and five years post-transplantation—most commonly skin cancer—according to a study published in the Journal of the American College of Cardiology.


Recent Headlines

HER2-targeted breast cancer treatments come with cardiovascular risks

Cardiotoxicity has been documented as a risk in cancer patients undergoing certain breast cancer therapies, but widely accepted international guidelines do not exist for dealing with those complications.

Researchers debut practice of monitoring mitochondria to predict, prevent cardiac arrest

New technology developed by researchers at Boston Children’s Hospital in conjunction with Cambridge-based Pendar Technologies has the ability to monitor oxygen levels in human tissue and predict cardiac arrest in heart patients, a study published in Science Translational Medicine reports.

FDA approves pump to treat right heart failure

The FDA has granted pre-market approval to the Impella RP heart pump used in treating right heart failure, Abiomed announced Sept. 20.

Abbott's PA sensor system is clinically proven to work—but how safe is it?

Recent studies have proven Abbott’s wireless pulmonary artery (PA) sensor CardioMEMS HF System to be successful in reducing heart failure hospitalizations and dramatically lowering medical costs, but a study published in the Journal of the American Medical Association this month questions the safety of the device.

Scientists dissect the reasons behind sudden cardiac death in triathlons

Triathlons could be risky for athletes with heart disease, potentially leading to cardiac arrest or sudden death, according to a new Minneapolis Heart Institute Foundation study.

New heart failure treatment increases ejection fraction by 38% in 1st clinical patient

The first clinical patient to undergo a new, less invasive treatment for heart failure has been discharged from University Hospital Zurich in Switzerland and is recovering well, according to a press release from BioVentrix.

Sudden cardiac death a significant contributor to mortality in women, regardless of CAD status

Sudden cardiac death is a significant contributor to mortality in women, regardless of presence of coronary artery disease (CAD), according to a six-year study published in the Journal of the American Heart Association.

Researchers link aldosterone, plasma renin activity to increased risk for CVD in black Americans

Increased levels of aldosterone and plasma renin activity (PRA) are associated with greater risk of cardiovascular disease (CVD) and all-cause mortality among blacks in the U.S., according to a community-based study.

Hearts with improving LVSD can be safely transplanted

Donor hearts with left ventricular systolic dysfunction (LVSD) can be revived and transplanted as successfully as other hearts, according to a study in the Journal of the American College of Cardiology.

6 data points about rheumatic heart disease as global rates decline

Over the past quarter-century, the worldwide burden of rheumatic heart disease has declined although high rates of the illness persist in certain poor regions, including Oceania, South Asia and sub-Saharan Africa, a new study finds.